These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
525 related articles for article (PubMed ID: 4353012)
21. Electrocardiographic changes following adriamycin treatment. Dindogru A; Barcos M; Henderson ES; Wallace HJ Med Pediatr Oncol; 1978; 5(1):65-71. PubMed ID: 745592 [TBL] [Abstract][Full Text] [Related]
22. Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin-D and mithramycin. Kushner JP; Hansen VL; Hammar SP Cancer; 1975 Nov; 36(5):1577-84. PubMed ID: 172214 [TBL] [Abstract][Full Text] [Related]
23. Cardiotoxicity of anthracycline antineoplastic drugs--Clinicopathological and experimental studies. Suzuki T; Kanda H; Kawai Y; Tominaga K; Murata K Jpn Circ J; 1979 Nov; 43(11):1000-8. PubMed ID: 522231 [No Abstract] [Full Text] [Related]
24. [Cardiotoxicity of doxorubicin in children]. Pilon JW; Naeff MS; Taminiau JA Ned Tijdschr Geneeskd; 1984 Jul; 128(28):1339-43. PubMed ID: 6482993 [No Abstract] [Full Text] [Related]
25. Adriamycin cardiotoxicity in stage IV breast cancer: possible enhancement with prior left chest radiation therapy. Kinsella TJ; Ahmann DL; Giuliani ER; Lie JT Int J Radiat Oncol Biol Phys; 1979; 5(11-12):1997-2002. PubMed ID: 397210 [No Abstract] [Full Text] [Related]
26. The cardiotoxicity of anticancer agents. Von Hoff DD; Rozencweig M; Piccart M Semin Oncol; 1982 Mar; 9(1):23-33. PubMed ID: 7071608 [TBL] [Abstract][Full Text] [Related]
31. Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals. Friedman MA; Bozdech MJ; Billingham ME; Rider AK JAMA; 1978 Oct; 240(15):1603-6. PubMed ID: 691145 [TBL] [Abstract][Full Text] [Related]
32. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?]. Reinhardt D; Hofmann V; Martz G Schweiz Med Wochenschr; 1985 Apr; 115(16):557-61. PubMed ID: 4001904 [TBL] [Abstract][Full Text] [Related]
33. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity. Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365 [TBL] [Abstract][Full Text] [Related]
34. Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer. Goorin AM; Chauvenet AR; Perez-Atayde AR; Cruz J; McKone R; Lipshultz SE J Pediatr; 1990 Jan; 116(1):144-7. PubMed ID: 2295956 [No Abstract] [Full Text] [Related]
35. [Cardioxan: prevention of anthracycline-related cardiotoxicity]. Gershanovich ML Vopr Onkol; 2004; 50(4):482-91. PubMed ID: 15605776 [No Abstract] [Full Text] [Related]
36. Prevention of doxorubicin-induced congestive heart failure by continuous intravenous infusion in multiple myeloma; a case report and review of the literature. Lieverse RJ; Ossenkoppele GJ Neth J Med; 1991 Feb; 38(1-2):33-4. PubMed ID: 2030807 [TBL] [Abstract][Full Text] [Related]
37. Adriamycin cardiotoxicity in children: case reports, literature review, and risk factors. Prout MN; Richards MJ; Chung KJ; Joo P; Davis HL Cancer; 1977 Jan; 39(1):62-5. PubMed ID: 188540 [TBL] [Abstract][Full Text] [Related]
38. Doxorubicin-induced cardiotoxicosis. Clinical features in 32 dogs. Mauldin GE; Fox PR; Patnaik AK; Bond BR; Mooney SC; Matus RE J Vet Intern Med; 1992; 6(2):82-8. PubMed ID: 1588546 [TBL] [Abstract][Full Text] [Related]
39. Effect of a 1-hour IV infusion of doxorubicin on the development of cardiotoxicity in dogs as evaluated by electrocardiography and echocardiography. Gillings S; Johnson J; Fulmer A; Hauck M Vet Ther; 2009; 10(1-2):46-58. PubMed ID: 19742448 [TBL] [Abstract][Full Text] [Related]